Patents Assigned to Epicor Medical, Inc.
  • Publication number: 20060135954
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: September 27, 2005
    Publication date: June 22, 2006
    Applicant: EPICOR MEDICAL, INC. A Delaware Corporation.
    Inventors: John Sliwa, Matthias Vaska, Jonathan Podmore, Roxanne Richman, Scott Anderson, Gerard Champsaur, John Crowe
  • Patent number: 7052493
    Abstract: The invention is related to methods of sizing an area around the pulmonary veins along an epicardial surface. A sizing element is provided which has a plurality of indicators along its length which is used to size an area around the pulmonary veins. A sizing element is wrapped around the pulmonary veins along an epicardial location. The size of an ablating device is determined by using the indicators on the sizing element. An ablating device is then selected based on this measurement. The ablating device is then attached to the sizing element. The ablating device is then wrapped around the pulmonary veins while manipulating the sizing element.
    Type: Grant
    Filed: September 24, 2002
    Date of Patent: May 30, 2006
    Assignee: Epicor Medical, Inc.
    Inventors: Matthias Vaska, John E. Crowe, Gary Henry Miller, Jonathan L. Podmore, Gerard Champsaur, Drew Hoffman, Casey Tansey
  • Patent number: 6971394
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: December 6, 2005
    Assignee: Epicor Medical, Inc.
    Inventors: John W. Sliwa, Jr., Matthias Vaska, Jonathan L. Podmore, Scott C. Anderson, Gerard Champsaur, John E. Crowe, Stephen A. Morse, Gary Henry Miller
  • Publication number: 20050251125
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Application
    Filed: June 28, 2004
    Publication date: November 10, 2005
    Applicant: EPICOR MEDICAL, INC.
    Inventors: Benjamin Pless, Scott Anderson, Jonathan Podmore, Matthias Vaska, John Crowe, Roxanne Richman, Timothy Ciciarelli, David Gallup, Jack Ulstad
  • Patent number: 6949095
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: September 27, 2005
    Assignee: Epicor Medical, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6929010
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: August 16, 2005
    Assignee: Epicor Medical, Inc.
    Inventors: Matthias Vaska, Banjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6858026
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Grant
    Filed: December 5, 2001
    Date of Patent: February 22, 2005
    Assignee: Epicor Medical, Inc.
    Inventors: John W. Sliwa, Jr., Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Publication number: 20050033274
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Application
    Filed: June 28, 2004
    Publication date: February 10, 2005
    Applicant: EPICOR MEDICAL, INC., A Delaware Corporation
    Inventors: Benjamin Pless, Scott Anderson, Jonathan Podmore, Matthias Vaska, John Crowe, Roxanne Richman, Timothy Ciciarelli, David Gallup, Jack Ulstad
  • Patent number: 6840936
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: January 11, 2005
    Assignee: Epicor Medical, Inc.
    Inventors: John W. Sliwa, Jr., Matthias Vaska, Jonathan L. Podmore, Scott C. Anderson, Gerard Champsaur, John E. Crowe, Stephen A. Morse, Gary Henry Miller
  • Patent number: 6805128
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: October 19, 2004
    Assignee: Epicor Medical, Inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Patent number: 6805129
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: October 19, 2004
    Assignee: Epicor Medical, inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Patent number: 6719755
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Grant
    Filed: June 19, 2001
    Date of Patent: April 13, 2004
    Assignee: Epicor Medical, Inc.
    Inventors: John W. Sliwa, Jr., Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Patent number: 6701931
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Grant
    Filed: December 5, 2001
    Date of Patent: March 9, 2004
    Assignee: Epicor Medical, Inc.
    Inventors: John W. Sliwa, Jr., Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Patent number: 6689128
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Grant
    Filed: December 5, 2001
    Date of Patent: February 10, 2004
    Assignee: Epicor Medical, Inc.
    Inventors: John W. Sliwa, Jr., Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Patent number: 6645202
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: November 11, 2003
    Assignee: Epicor Medical, Inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.